Key Data As To Why Shares In electroCore, Inc. (ECOR) Are Trading Lower
ElectroCore, Inc. (ECOR), a Medical Instruments & Supplies business, was a market gainer in the stock market session. electroCore, Inc. (ECOR) stock started the day for trading at $1.1100 and closed the day at $1.0600 with losses of -4.50%. The decrease movement in electroCore, Inc. (ECOR) lagged the movement in the S&P 500 for the day which gained +1.39% in stock market session.
electroCore, Inc. (ECOR) is focused on the Medical Instruments & Supplies sector. This stock market sector has seen some movement from day traders in recent trading sessions. Bullish day traders of electroCore, Inc. (ECOR) will be looking for positive upcoming earnings whereas bearish day traders of electroCore, Inc. (ECOR) will be looking for negative earnings. The last time electroCore, Inc. (ECOR) had an earnings surprise was on Qtr Ending 12/19 when they reported -$0.29 compared to an estimate of -$0.30 which was a difference of $+0.01 resulting in a change of +3.33%. Current earnings estimates are to be released for Current Qtr 03/2020 on electroCore, Inc. (ECOR) and out of 1 Wall Street estimates the average is saying -$0.25. The high estimate is saying -$0.25 whereas the low estimate is saying -$0.25 and the prior year electroCore, Inc. (ECOR) announced earnings at -$0.47 a growth rate est. (year over year) of +46.81%.
The market performance of electroCore, Inc. (ECOR) has varied recently. Year to date electroCore, Inc. (ECOR)’s shares are down -33.33%. Over the past 12 weeks electroCore, Inc. (ECOR) is down -12.40% and over the last 4 weeks electroCore, Inc. (ECOR) is up 127.96%. electroCore, Inc. (ECOR) current income statement shows revenue (ttm) of $2.39M. Gross Profit is $1.23M. This puts the current EBITDA of electroCore, Inc. (ECOR) at $-43.98M.
Wall street day traders might also notice recent changes to stock analyst estimates for electroCore, Inc. (ECOR). The stock is trading with an RSI (relative strength index) of 56.55 indicating electroCore, Inc. (ECOR) is neither overbought nor oversold. Technically, ECOR’s short term support levels are around $79.27, $78.28 and $77.36 on the downside. ECORs short term resistance levels are $85.17, $80.98 and $80.27 on the upside. The market cap of electroCore, Inc. (ECOR) is $31.757M and institutions hold 10.27% of the stock. The outstanding share count stands at 31.89M while the short float (shares short) stands at 7.80%.
Market research indicates that these financial estimate changes look to be directly correlated with short-term stock prices. The day traders can look to capitalize on the basis of ranking. electroCore, Inc. (ECOR) has short term rating of Neutral (0.04), Intermediate rating of Neutral (-0.06) and long-term rating of Neutral (0.07) giving electroCore, Inc. (ECOR) an overall rating of Neutral (0.02).
The EPS growth this year on electroCore, Inc. (ECOR) is increased 19.40% and is expected to increase 32.40% next year. However, quarterly earnings (EPS) growth year over year on electroCore, Inc. (ECOR) has increased by 45.00% and quarterly revenue (Sales) growth year over year stands at 75.00%. Gross margin is detected at 51.60% that represents the percent of total sales revenue that the company retains after direct cost of goods sold. Return on equity (ttm) is -120.70%.
2020-04-17 – Electrocore Provides Business Update And Select First Quarter 2020 Guidance. 2020-03-23 – Electrocore, Inc. – Suspending Revenue Guidance. 2020-01-13 – Electrocore Sees FY 2020 Revenue Between $7 Million And $9 Million. 2019-12-27 – electrocore Announces Board Of Directors Transition. 2019-11-13 – ElectroCore Third Quarter 2019 Financial Results.
Electrocore, LLC operates as a bio-electronic medicine company. It reseraches and develops therapeutic technologies based in neurology and rheumatology. Electrocore, LLC is based in NJ, United States.